However, since treatment of FH-1 during pregnancy is for the mother and not for the fetus, it seems logical to select the most potent ACTH-suppressive treatment with dexamethasone and prefer the lowest dose that warrants normotension and control of hypokalemia in case of BP values increase and serum K+ levels fall during the 3rd trimester. This evidence concerns the gene POMC and Hypokalemia.